ArticleFrontiers in immunology2025
Positive associations between triglyceride-glucose (TyG) and TyG-body mass index (TyG-BMI) with cardiovascular disease in patients with psoriasis: cross-sectional results from the SPEECH.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- Sex-Specific Associations of Triglyceride-Glucose Index and a Body Shape Index with Cardiometabolic Multimorbidity Risk: A Prospective Cohort Study.Journal of clinical medicine · 2026Article
- Integrated Assessment of Inflammatory and Lipid-Metabolic Biomarkers in Psoriasis: Implications for Metabolic Syndrome.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with psoriasis have an increased risk of developing cardiovascular disease(CVD), yet reliable potential markers for cardiovascular risk assessment remain insufficient. The triglyceride-glucose (TyG) index and TyG-body mass index (TyG-BMI) have been identified as potential indicators of metabolic and cardiovascular risk in the general population. However, their specific role in psoriasis-related CVD has not been systematically evaluated. Objective: This study aimed to investigate the relationship between TyG index, TyG-BMI index and CVD in patients with psoriasis. Methods: This cross-sectional study utilized data from the Shanghai Psoriasis Efficacy Evaluation Cohort (SPEECH), which includes Chinese patients with moderate to severe psoriasis. Defined by strict inclusion and exclusion criteria, 1112 psoriasis patients were included. CVD included any cerebrovascular events and coronary atherosclerotic heart disease. Multivariate logistic regression and restricted cubic spline analysis (RCS) were used to examine the relationship between TyG index, TyG-BMI index, and CVD risk. Subgroup and sensitivity analyses were conducted to validate the robustness of the findings. Results: Among the study participants, 223 (20.1%) had CVD. Compared to non-CVD patients, those with CVD were older, had a higher BMI, a higher prevalence of hypertension and diabetes, a longer course of psoriasis, higher levels of blood glucose, triglycerides, and higher levels of TyG index and TyG-BMI index. Subsequent multivariate logistic regression analysis showed a significant positive association between TyG index, TyG-BMI index with CVD risk in psoriasis patients. RCS analysis showed that there was a dose-response relationship between TyG index and TyG-BMI index with CVD risk. Subgroup analysis showed that TyG index and TyG-BMI index were significantly associated with CVD in most subgroups. Patients who were excluded from systematic therapy were subjected to sensitivity analysis, and the results were consistent with the main analysis, suggesting a robust correlation between TyG index and TyG-BMI index and CVD. Conclusion: Elevated TyG and TyG-BMI indices are independently associated with CVD in psoriasis patients, suggesting their potential as practical markers for cardiovascular risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.